JTCS St. Jude Medical
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roeslin, N.
Right arrow Articles by Witz, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roeslin, N.
Right arrow Articles by Witz, J. P.

The Journal of Thoracic and Cardiovascular Surgery, Vol 94, 504-509, Copyright © 1987 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

A better prognostic value from a modification of lung cancer staging

N Roeslin, G Chalkiadakis, P Dumont and JP Witz
Service de Chirurgie Thoracique, C.H.U. de Strasbourg, France.

This prospective study analyzes the survival rate, according to TNM and staging, of 538 patients who underwent curative pulmonary resection for non-oat cell tumors and who survived the operative period. A total of 279 patients had Stage I disease, 113 Stage II, and 146 Stage III. The overall survival rates were 72% at 1 year, 54% at 2 years, 47% at 3 years, 43% at 4 years, and 39% at 5 years. The survival curves of Stages I, II, and III are significantly different. Nevertheless, in Stage I, T1 N0 tumors presented the best survival rate (71% at 5 years), and this was significantly different from those of all other groups. For Stage II, the survival curves were significantly different according to hilar or lobar location of N1. The survival rate of T2 N1 hilar tumors was similar to that of T2 N2 tumors. In Stage III, the survival of T3 N2 tumors was the worst of all classifications. These results may contribute to a reappraisal of the surgical classification. T1 N0 tumors are worthy, on their own, of forming Stage I. T2 N0, T1 N1 lobar, and T2 N1 lobar can constitute Stage II. Stage III or IIIa would comprise carcinomas classified T2 N1 hilar, T1 N2, T2 N2, and perhaps T3 N0 and T3 N1. T3 N2 should probably be isolated in a IIIb or IV stage.


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
H. Asamura, K. Suzuki, H. Kondo, and R. Tsuchiya
Where is the boundary between N1 and N2 stations in lung cancer?
Ann. Thorac. Surg., December 1, 2000; 70(6): 1839 - 1846.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
G. Massard, R. Kessler, B. Gasser, X. Ducrocq, S. Elia, S. Gouzou, and J.-M. Wihlm
Local control of disease and survival following bronchoplastic lobectomy for non-small cell lung cancer
Eur. J. Cardiothorac. Surg., September 1, 1999; 16(3): 276 - 282.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. Massard, A. Dabbagh, P. Dumont, R. Kessler, N. Roeslin, J.-M. Wihlm, and G. Morand
Are Bilobectomies Acceptable Procedures?
Ann. Thorac. Surg., September 1, 1995; 60(3): 640 - 645.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Funatsu, Y. Matsubara, S. Ikeda, R. Hatakenaka, T. Hanawa, and H. Ishida
Preoperative mediastinoscopic assessment of N factors and the need for mediastinal lymph node dissection in T1 lung cancer
J. Thorac. Cardiovasc. Surg., August 1, 1994; 108(2): 321 - 328.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1987 by The American Association for Thoracic Surgery.